Cardiovascular Systems, Inc. Announces Acquisition of Peripheral Support Catheters From WavePoint Medical, LLC
Retrieved on:
월요일, 3월 22, 2021
Biotechnology, Surgery, Medical devices, Health, Cardiology, Catheters, Medical specialties, Medicine, Interventional radiology, Clinical medicine, Peripheral artery disease, Balloon catheter, Atherectomy, Cordis, WavePoint Medical, LLC, Cardiovascular Systems, Inc., Coronary Artery Disease (CAD), Peripheral Artery Disease (PAD)
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) announced today that it has acquired a line of peripheral support catheters from WavePoint Medical, LLC.
Key Points:
- Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) announced today that it has acquired a line of peripheral support catheters from WavePoint Medical, LLC.
- Peripheral support catheters are used during peripheral vascular intervention (PVI) procedures for guidewire support to enable lesion crossing, as well as for guidewire exchanges.
- Scott R. Ward, Chairman, President and Chief Executive Officer of CSI, said, With the acquisition of these peripheral support catheters, CSI will soon offer a complete portfolio of products for the treatment of peripheral artery disease, including atherectomy, balloon catheters, guidewires, support catheters and embolic protection.
- WavePoint Medical LLC, a MedVenture Holdings portfolio company, is a Utah based medical device development company focused on high-performance micro-catheters for the interventional cardiovascular markets.